Literature DB >> 25389563

The systematic assessment of traditional evidence from the premodern Chinese medical literature: a text-mining approach.

Brian H May1, Anthony Zhang, Yubo Lu, Chuanjian Lu, Charlie C L Xue.   

Abstract

OBJECTIVES: This project aimed to develop an approach to evaluating information contained in the premodern Traditional Chinese Medicine (TCM) literature that was (1) comprehensive, systematic, and replicable and (2) able to produce quantifiable output that could be used to answer specific research questions in order to identify natural products for clinical and experimental research.
METHODS: The project involved two stages. In stage 1, 14 TCM collections and compendia were evaluated for suitability as sources for searching; 8 of these were compared in detail. The results were published in the Journal of Alternative and Complementary Medicine. Stage 2 developed a text-mining approach for two of these sources.
RESULTS: The text-mining approach was developed for Zhong Hua Yi Dian; Encyclopaedia of Traditional Chinese Medicine, 4th edition) and Zhong Yi Fang Ji Da Ci Dian; Great Compendium of Chinese Medical Formulae). This approach developed procedures for search term selection; methods for screening, classifying, and scoring data; procedures for systematic searching and data extraction; data checking procedures; and approaches for analyzing results. Examples are provided for studies of memory impairment and diabetic nephropathy, and issues relating to data interpretation are discussed.
CONCLUSIONS: This approach to the analysis of large collections of the premodern TCM literature uses widely available sources and provides a text-mining approach that is systematic, replicable, and adaptable to the requirements of the particular project. Researchers can use these methods to explore changes in the names and conceptions of a disease over time, to identify which therapeutic methods have been more or less frequently used in different eras for particular disorders, and to assist in the selection of natural products for research efforts.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25389563     DOI: 10.1089/acm.2013.0372

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  6 in total

1.  Acupuncture for cancer pain: protocol for a pilot pragmatic randomised controlled trial.

Authors:  Yihan He; Brian H May; Anthony Lin Zhang; Xinfeng Guo; Yihong Liu; Yanchun Qu; Xuesong Chang; Chuan-Jian Lu; Charlie Changli Xue; Haibo Zhang
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

Review 2.  Herbal formula (Danggui Beimu Kushen Wan) for prostate disorders: a systematic review of classical literature.

Authors:  Hong Li; Andrew Hung; Angela Wei Hong Yang
Journal:  Integr Med Res       Date:  2019-08-31

Review 3.  Natural product drug discovery in the artificial intelligence era.

Authors:  F I Saldívar-González; V D Aldas-Bulos; J L Medina-Franco; F Plisson
Journal:  Chem Sci       Date:  2021-12-13       Impact factor: 9.825

4.  Application of Ferulic Acid for Alzheimer's Disease: Combination of Text Mining and Experimental Validation.

Authors:  Guilin Meng; Xiulin Meng; Xiaoye Ma; Gengping Zhang; Xiaolin Hu; Aiping Jin; Yanxin Zhao; Xueyuan Liu
Journal:  Front Neuroinform       Date:  2018-05-29       Impact factor: 4.081

5.  Chinese Herbal Medicines for Rheumatoid Arthritis: Text-Mining the Classical Literature for Potentially Effective Natural Products.

Authors:  Xuan Xia; Brian H May; Anthony Lin Zhang; Xinfeng Guo; Chuanjian Lu; Charlie C Xue; Qingchun Huang
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-28       Impact factor: 2.629

6.  Application of the Delphi Method in the Construction of an Evaluating and Grading Scale for Evidence of Disease Prevention and Treatment in Ancient Books of Traditional Chinese Medicine.

Authors:  Lei Zhang; Xinfeng Guo; Shuo Yang; Sihong Liu; Hongtao Li; Guangkun Chen; Hongjie Gao; Huamin Zhang; Lin Tong
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-01       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.